OA12.06 Neoadjuvant Durvalumab + Chemotherapy Followed by Adjuvant Durvalumab in Resectable EGFR-mutated NSCLC (AEGEAN)
Journal of Thoracic Oncology(2023)
关键词
neoadjuvant durvalumab,chemotherapy,nsclc,egfr-mutated
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要